Anatara Lifesciences Ltd has released a press release.
Investor Presentation and Strategy Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
In the deck
Earlier from Anatara Lifesciences
- Anatara CEO announces retirement
- Exclusive Global License Agreement with Zoetis
- FDA approves the Human Food Safety Dossier
- R&D Tax Incentive Received
- Pork CRC Options extended by 12 Months
Later from Anatara Lifesciences
- Appendix 4E & Audited Financial Statements
- APVMA approval for Detach
- Chief Executive Officer Appointment
- R&D Tax Refund Received
- Successful proof of concept studies
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences